These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream. Taylor AM; Liu B; Mari Y; Liu B; Repa JJ J Lipid Res; 2012 Nov; 53(11):2331-42. PubMed ID: 22892156 [TBL] [Abstract][Full Text] [Related]
4. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. Bieghs V; Verheyen F; van Gorp PJ; Hendrikx T; Wouters K; Lütjohann D; Gijbels MJ; Febbraio M; Binder CJ; Hofker MH; Shiri-Sverdlov R PLoS One; 2012; 7(3):e34378. PubMed ID: 22470565 [TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C. Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767 [TBL] [Abstract][Full Text] [Related]
6. Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment. Houben T; Yadati T; de Kruijf R; Gijbels MJJ; Luiken JJFP; van Zandvoort M; Kapsokalyvas D; Lütjohann D; Westerterp M; Plat J; Leake D; Shiri-Sverdlov R Front Immunol; 2021; 12():716357. PubMed ID: 34489968 [TBL] [Abstract][Full Text] [Related]
7. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737 [TBL] [Abstract][Full Text] [Related]
8. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice. van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease. Tanaka Y; Yamada Y; Ishitsuka Y; Matsuo M; Shiraishi K; Wada K; Uchio Y; Kondo Y; Takeo T; Nakagata N; Higashi T; Motoyama K; Arima H; Mochinaga S; Higaki K; Ohno K; Irie T Biol Pharm Bull; 2015; 38(6):844-51. PubMed ID: 26027824 [TBL] [Abstract][Full Text] [Related]
10. Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C. Yamada Y; Ishitsuka Y; Kondo Y; Nakahara S; Nishiyama A; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kamei S; Shuto T; Kai H; Hayashino Y; Sugita M; Kikuchi T; Hirata F; Miwa T; Takeda H; Orita Y; Seki T; Ohta T; Kurauchi Y; Katsuki H; Matsuo M; Higaki K; Ohno K; Matsumoto S; Era T; Irie T Br J Pharmacol; 2021 Jul; 178(13):2727-2746. PubMed ID: 33782944 [TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular 2-hydroxypropyl-γ-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann-Pick disease type C. Yamada Y; Ishitsuka Y; Fukaura-Nishizawa M; Kawata T; Ishii A; Shirakawa A; Sakai T; Tanaka M; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Seki T; Kurauchi Y; Katsuki H; Higaki K; Ikeda R; Matsuo M; Era T; Irie T Life Sci; 2024 Aug; 350():122776. PubMed ID: 38852794 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells. Egele K; Samaddar S; Schneider N; Thompson D; Wenz G J Mater Chem B; 2019 Jan; 7(4):528-537. PubMed ID: 31372225 [TBL] [Abstract][Full Text] [Related]
14. Cyclodextrins applied to the treatment of lysosomal storage disorders. Ishitsuka Y; Irie T; Matsuo M Adv Drug Deliv Rev; 2022 Dec; 191():114617. PubMed ID: 36356931 [TBL] [Abstract][Full Text] [Related]
15. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease. Tamura A; Yui N J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063 [TBL] [Abstract][Full Text] [Related]
16. Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics. Cougnoux A; Pergande MR; Serna-Perez F; Cologna SM J Am Soc Mass Spectrom; 2023 Apr; 34(4):668-675. PubMed ID: 36920149 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. Yao J; Ho D; Calingasan NY; Pipalia NH; Lin MT; Beal MF J Exp Med; 2012 Dec; 209(13):2501-13. PubMed ID: 23209315 [TBL] [Abstract][Full Text] [Related]
18. Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation. Bieghs V; Walenbergh SM; Hendrikx T; van Gorp PJ; Verheyen F; Olde Damink SW; Masclee AA; Koek GH; Hofker MH; Binder CJ; Shiri-Sverdlov R Liver Int; 2013 Aug; 33(7):1056-61. PubMed ID: 23617943 [TBL] [Abstract][Full Text] [Related]
19. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Nuotio-Antar AM; Hachey DL; Hasty AH Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220 [TBL] [Abstract][Full Text] [Related]